PD153035 Hydrochloride
Cat. No.:YN340095
CAS No. :183322-45-4
产品名称: | PD153035 Hydrochloride |
CAS No.: | 183322-45-4 |
Chemical Name: | N-(3-bromophenyl)-6,7-dimethoxy-4-quinazolinamine, monohydrochloride |
Synonyms: | SU-5271 Hydrochloride; AG1517 Hydrochloride; ZM 252868 Hydrochloride |
分子量: | 396.67 |
分子式: | C₁₆H₁₅BrClN₃O₂ |
SMILES: | COC1=C(C=C(C2=C1)N=CN=C2NC3=CC(Br)=CC=C3)OC.Cl |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | PD153035 Hydrochloride (SU-5271 Hydrochloride) 是有效地EGFR抑制剂,Ki和IC50值分别为6和25 pM。 |
IC50和靶点: | [{name:"EGFR:6 pM (Ki)"},{name: "EGFR:25 pM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Ciardiello, F., and Tortora, G.A novel approach in the treatment of cancer: Targeting the epidermal growth factor receptorClin. Cancer Res.7(10),2958-2970(2001)
Fry, D.W., Kraker, A.J., McMichael, A., et al.A specific inhibitor of the epidermal growth factor receptor tyrosine kinaseScience265(5175),1093-1095(1994)
Bos, M., Mendelsohn, J., Kim, Y.M., et al.PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent mannerClin. Cancer Res.3(11),2099-2106(1997)
Rae, J.M., and Lippman, M.E.Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitorsBreast Cancer Res. Treat.83(2),99-107(2004)